Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol

被引:64
作者
Domenig, C
Sanchez-Fueyo, A
Kurtz, J
Alexopoulos, SP
Mariat, C
Sykes, M
Strom, TB [1 ]
Zheng, XX
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplantat Res Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02114 USA
关键词
D O I
10.4049/jimmunol.175.1.51
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The induction of mixed chimerism (MC) is a powerful and effective means to achieve transplantation tolerance in rodent models. Host conditioning with irradiation or cytotoxic drugs has been used in many protocols for chimeric induction across allogeneic barriers. The deletion of alloreactive T cell clones has been described as the main mechanism responsible for the induction of a stable MC. In this study, we demonstrate that a stable MC and skin allograft tolerance can be established across MHC barriers by a noncytotoxic, irradiation-free approach using costimulation blockade plus rapamycin treatment. By using an adoptive transfer model of skin allograft and using specific V beta TCR probes, we demonstrated that deletion of donor-reactive cytopathic T cell clones is indeed profound in tolerant hosts. Nonetheless, the challenge of tolerant mixed chimeras with 5 million mononuclear leukocytes (MNL) from naive syngeneic mice was neither able to abolish the stable MC nor to trigger skin allograft rejection, a hallmark of peripheral, not central tolerance. Furthermore, in an adoptive transfer model, MNLs harvested from tolerant hosts significantly inhibited the capacity of naive MNLs to reject same donor, but not third-party, skin allografts. Moreover, when we transplanted skin allografts from stable tolerant chimeras onto syngeneic immune-incompetent mice, graft-infiltrating T cells migrated from the graft site, expanded in the new host, and protected allografts from acute rejection by naive syngeneic MNLs. In this model, both deletional and immunoregulatory mechanisms are active during the induction and/or maintenance of allograft tolerance through creation of MC using a potentially clinically applicable regimen.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 48 条
[1]   MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE [J].
BACHARLUSTIG, E ;
RACHAMIM, N ;
LI, HW ;
LAN, FS ;
REISNER, Y .
NATURE MEDICINE, 1995, 1 (12) :1268-1273
[2]   The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade [J].
Blaha, P ;
Bigenzahn, S ;
Koporc, Z ;
Schmid, M ;
Langer, F ;
Selzer, E ;
Bergmeister, H ;
Wrba, F ;
Kurtz, J ;
Kiss, C ;
Roth, E ;
Muehlbacher, F ;
Sykes, M ;
Wekerle, T .
BLOOD, 2003, 101 (07) :2886-2893
[3]   Infectious tolerance [J].
Cobbold, S ;
Waldmann, H .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :518-524
[4]  
Colson YL, 1996, J IMMUNOL, V157, P2820
[5]  
DOWN JD, 1993, EXP HEMATOL, V21, P913
[6]   Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning [J].
Durham, MM ;
Bingaman, AW ;
Adams, AB ;
Ha, JW ;
Waitze, SY ;
Pearson, TC ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :1-4
[7]   An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection [J].
Ferrari-Lacraz, S ;
Zheng, XX ;
Kim, YS ;
Li, YS ;
Maslinski, W ;
Li, XC ;
Strom, TB .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3478-3485
[8]   Identification of regulatory T cells in tolerated allografts [J].
Graca, L ;
Cobbold, SP ;
Waldmann, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) :1641-1646
[9]   SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE .3. FURTHER CHARACTERIZATION OF THE CD4+ SUPPRESSOR-CELL AND ITS MECHANISMS OF ACTION [J].
HALL, BM ;
PEARCE, NW ;
GURLEY, KE ;
DORSCH, SE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :141-157
[10]   IL-30 is required for regulatory T cells to mediate tolerance to alloantigens in vivo [J].
Hara, M ;
Kingsley, CI ;
Niimi, M ;
Read, S ;
Turvey, SE ;
Bushell, AR ;
Morris, PJ ;
Powrie, F ;
Wood, KJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3789-3796